Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $59,880 |
Sells | 13 | $1,903,013 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
07 Mar 2024 16:05 | AMLX | Amylyx Pharmaceuticals Inc | COHEN JOSHUA B | Co-Chief Executive Officer | 05 Mar 2024 | Sale | 4,135 | 18.7279 | 77,440 | D |
07 Mar 2024 16:05 | AMLX | Amylyx Pharmaceuticals Inc | KLEE JUSTIN B. | Co-Chief Executive Officer | 05 Mar 2024 | Sale | 4,135 | 18.7279 | 77,440 | D |
07 Mar 2024 16:05 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 05 Mar 2024 | Sale | 1,792 | 18.7279 | 33,560 | D |
07 Mar 2024 16:05 | AMLX | Amylyx Pharmaceuticals Inc | MAZZARIELLO GINA | Chief Legal Officer | 05 Mar 2024 | Sale | 1,540 | 18.7279 | 28,841 | D |
27 Feb 2024 17:59 | AMLX | Amylyx Pharmaceuticals Inc | MAZZARIELLO GINA | Chief Legal Officer | 23 Feb 2024 | Sale | 2,838 | 18.7564 | 53,231 | D |
11 Jan 2024 17:11 | AMLX | Amylyx Pharmaceuticals Inc | KLEE JUSTIN B. | Co-Chief Executive Officer | 09 Jan 2024 | Sale | 5,841 | 16.3281 | 95,372 | D |
11 Jan 2024 17:11 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 09 Jan 2024 | Sale | 2,716 | 16.3281 | 44,347 | D |
11 Jan 2024 17:10 | AMLX | Amylyx Pharmaceuticals Inc | COHEN JOSHUA B | Co-Chief Executive Officer | 09 Jan 2024 | Sale | 5,841 | 16.3281 | 95,372 | D |
11 Jan 2024 17:04 | AMLX | Amylyx Pharmaceuticals Inc | YERAMIAN PATRICK D | Chief Medical Officer | 09 Jan 2024 | Sale | 2,812 | 16.3281 | 45,915 | D |
19 Dec 2023 16:37 | AMLX | Amylyx Pharmaceuticals Inc | FIRESTONE KAREN | Director | 15 Dec 2023 | Purchase | 4,000 | 14.97 | 59,880 | D |
17 Aug 2023 16:35 | AMLX | Amylyx Pharmaceuticals Inc | MAZZARIELLO GINA | Chief Legal Officer | 15 Aug 2023 | Sale | 6,164 | 20.8771 | 128,686 | D |
18 May 2023 20:54 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 16 May 2023 | Sale | 500 | 27.6 | 13,800 | D |
18 May 2023 20:54 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 16 May 2023 | Sale | 32,000 | 26.9266 | 861,651 | D |
17 May 2023 16:58 | AMLX | Amylyx Pharmaceuticals Inc | YERAMIAN PATRICK D | Chief Medical Officer | 15 May 2023 | Sale | 11,965 | 29.0312 | 347,358 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)